Aurobindo Pharma Australia Overview

  • Status

  • Acquired/​Merged

  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 1

Aurobindo Pharma Australia General Information

Description

Manufacturer of semi-synthetic penicillin. The company also supply medicines for neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Acquirer
Eris Pharma
Primary Office
  • P.O. Box Number:-4039, Macquarie Shopping Centre
  • North Ryde
  • Sydney, New South Wales
  • Australia

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aurobindo Pharma Australia Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aurobindo Pharma Australia‘s full profile, request access.

Request a free trial

Aurobindo Pharma Australia Executive Team (3)

Name Title Board Seat Contact Info
Kishore Parimi Manager & Controller, Finance & Supply Chain
Kaio Bhamgara Regional Sales Manager
Cornelia Abraham Regulatory Affairs Manager
To view Aurobindo Pharma Australia’s complete executive team members history, request access »

Aurobindo Pharma Australia Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aurobindo Pharma Australia‘s full profile, request access.

Request a free trial